Tianjin Ringpu Bio-Technology Co., Ltd. logo

Tianjin Ringpu Bio-Technology Co., Ltd. (300119)

Market Open
10 Aug, 06:57
XSHE XSHE
¥
18. 38
+0.18
+0.989%
¥
9.01B Market Cap
- P/E Ratio
1.2% Div Yield
3.77M Volume
- Eps
¥ 18.2
Previous Close
Add Transaction
Day Range
18 18.39
Year Range
13.91 24.03
Want to track 300119 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300119 trading today higher at ¥18.38, an increase of 0.989% from yesterday's close, completing a monthly increase of 27.4619% or ¥3.96. Over the past 12 months, 300119 stock lost -2.0256%.
300119 pays dividends to its shareholders, with the most recent payment made on May 13, 2026. The next estimated payment will be in In 9 months on May 13, 2027 for a total of ¥0.4.
The last earnings report, released on Mar 31, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0777%, based on the last three reports.
Tianjin Ringpu Bio-Technology Co., Ltd. has completed 3 stock splits, with the recent split occurring on Apr 22, 2014.
The company's stock is traded on one exchange.

300119 Chart

People also search for

Dr Corp Ltd.
¥ 23.68
-1.0447%
Sunvim Group Co., Ltd.
¥ 11.97
-1.2376%
Tibet Gaozheng Explosive Co., Ltd.
¥ 59
-0.9735%
Innovative Medical Management Co., Ltd.
¥ 21.68
-1.0949%
Henan Liliang Diamond Co., Ltd.
¥ 58.62
-2.3488%

Tianjin Ringpu Bio-Technology Co., Ltd. (300119) FAQ

What is the stock price today?

The current price is ¥18.38.

On which exchange is it traded?

Tianjin Ringpu Bio-Technology Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300119.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.2%.

What is its market cap?

As of today, the market cap is 9.01B.

Has Tianjin Ringpu Bio-Technology Co., Ltd. ever had a stock split?

Tianjin Ringpu Bio-Technology Co., Ltd. had 3 splits and the recent split was on Apr 22, 2014.

Tianjin Ringpu Bio-Technology Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Lei Xu CEO
XSHE Exchange
CNE100000TV1 ISIN
CN Country
2,900 Employees
13 May 2026 Last Dividend
4 May 2012 Last Split
17 Sep 2010 IPO Date

Overview

Tianjin Ringpu Bio-Technology Co.,Ltd., headquartered in Tianjin, China since 1998, specializes in the research, development, production, and sale of veterinary products. Their expansive portfolio covers a wide range of veterinary raw materials, drug preparation, functional additives, and veterinary biological products. The company targets a diverse array of animals, including poultry, waterfowl, livestock, and pets, ensuring broad coverage within the veterinary healthcare sector.

Products and Services

The company's offerings can be categorized as follows:

  • Vaccines and Drugs for Animals: This includes a variety of vaccines and medication tailored for poultry, waterfowl, livestock, and other animals, ensuring their health and productivity.
  • Pet Products: Tianjin Ringpu provides a comprehensive range of pet care products. These include:
    • Insect repellent series to protect pets from pests.
    • Ear products designed for pet ear health.
    • Nutritional supplements to support overall pet well-being.
    • Anesthesia for surgery, facilitating safe veterinary procedures.
    • Anti-infective and antiviral medications to combat infections and viruses.
    • Benazepril hydrochloride chewable tablets for cardiovascular health.
    • Meloxicam tablets for pain and inflammation relief.
    • Benzyl trimethylammonium chloride solution for various therapeutic uses.
  • Waterfowl Products: Including live/inactivated vaccines and refined egg yolk antibodies for ducks and goslings, such as duck tempusu vaccine, gosling plague antibody, duck serositis vaccine, and vaccines for viral hepatitis and duck plague.
  • Ruminant Products: A selection designed for ruminants, including cefquinome sulfate breast injection and ceftiofur hydrochloride injection, among others, for treating infections.
  • Livestock Products: Ranging from antibiotics like ceftiofur and florfenicol to nutritional additives such as tyvalin tartrate premix, tailored to ensure the health of livestock.
  • Active Pharmaceutical Ingredients (APIs): Tianjin Ringpu also specializes in the production of APIs such as tilmicosin, florfenicol, and warnemulin hydrochloride, integral for creating various veterinary drugs.
  • Cleaning Solutions: Offering products like potassium persulfate complex powder and glutaraldehyde decyl ammonium bromide solution for hygiene and sanitation applications.

Contact Information

Address: No. 1, East 9th Road, Tianjin, China, 300308
Phone: 86 22 8895 8118